Fungal Diseases News

Contamination of the health care environments near patients who are colonized with Candida auris often occurs within 4 hours, researchers found.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Hospital-associated infections declined significantly at acute-care hospitals in 2022, although rates at other health care facilities remained relatively stagnant, according to a CDC report.

Nearly half of infectious diseases fellowship programs were not filled on Match Day as the number of applicants declined despite an increase in certified ID programs, the Infectious Diseases Society of America announced.

We caught up with Mary Foote, MD, MPH, at IDWeek to ask how she got “Hooked on ID.”

In-house PCR testing on admission for the detection Candida auris enabled researchers to identify more cases on admission and lowered rates of hospital-onset C. auris, a recent study showed.

Why ID? Cue the iconic theme music from the medical drama House.